Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates
- PMID: 33775749
- DOI: 10.1016/j.jvs.2021.02.045
Revascularization of intermittent claudicants leads to more chronic limb-threatening ischemia and higher amputation rates
Abstract
Background: There is an increasing incidence of peripheral arterial disease (PAD). The most common symptomatic presentation of PAD is intermittent claudication (IC), reproducible leg pain with ambulation. The progression of symptoms beyond IC is rare, and a nonprocedural approach of smoking cessation, supervised exercise therapy, and best medical therapy can mitigate progression of IC. Despite the lack of limb- or life-threatening sequelae of IC, invasive treatment strategies of IC have experienced rapid growth. Within our health care system, PAD is treated by multiple disciplines with varying practice patterns, providing an opportunity to investigate the progression of IC based on treatment strategy. This study aims to compare PAD progression and amputation in patients with IC with and without revascularization.
Methods: This institutional review board-approved, single institute retrospective study reviewed all patients with an initial diagnosis of IC between June 11, 2003, and April 24, 2019. Revascularization was defined as endovascular or open. Time to chronic limb-threatening ischemia (CLTI) diagnosis and amputation were stratified by revascularization status using the Kaplan-Meier method. The association between revascularization status and each of CLTI progression and amputation using multivariable Cox regression, adjusting for demographic and clinical potential confounding variables was assessed.
Results: We identified 1051 patients who met the inclusion criteria. Of these patients, 328 had at least one revascularization procedure and 723 did not. The revascularized group was younger than the nonrevascularized group (60.3 years vs 62.1 years; P = .013). There was no significant difference in sex or comorbidities in the two groups other than a higher rate of diabetes mellitus type 2 (32.3% vs 16.3%; P < .001) and COPD (4.3% vs 1.7%; P = .017) in the revascularized group. Multivariable Cox regression found revascularization of patients with IC to be significantly associated with the progression to CLTI (hazard ratio, 2.9; 95% confidence interval, 2.0-4.2) and amputation (hazard ratio, 4.5; 95% confidence interval, 2.2-9.5). These findings were also demonstrated in propensity-matched cohorts of 218 revascularized and 340 nonrevascularized patients.
Conclusions: Revascularization of patients with IC is associated with an increased rate of progression to CLTI and increased amputation rates. Given these findings, further studies are required to identify which, if any, patients with IC benefit from revascularization procedures.
Keywords: Amputation; CLTI; Intermittent Claudication; Revascularization.
Published by Elsevier Inc.
Similar articles
-
Reinterventions in Patients with Claudication and Chronic Limb Threatening Ischemia.Ann Vasc Surg. 2022 Feb;79:56-64. doi: 10.1016/j.avsg.2021.07.050. Epub 2021 Oct 14. Ann Vasc Surg. 2022. PMID: 34656724
-
Risk Factor Analysis and Long-Term Outcomes in Patients with Endovascular Revascularization for Intermittent Claudication or Chronic Limb-Threatening Ischemia.Ann Vasc Surg. 2023 Feb;89:261-268. doi: 10.1016/j.avsg.2022.09.038. Epub 2022 Sep 24. Ann Vasc Surg. 2023. PMID: 36162626
-
Characteristics, Antithrombotic Patterns, and Prognostic Outcomes in Claudication and Critical Limb-Threatening Ischemia Undergoing Endovascular Therapy.J Endovasc Ther. 2024 Aug;31(4):622-633. doi: 10.1177/15266028221134886. Epub 2022 Nov 23. J Endovasc Ther. 2024. PMID: 36416475 Free PMC article.
-
The Double Burden: Deciphering Chronic Limb-Threatening Ischemia in End-Stage Renal Disease.Ann Vasc Surg. 2024 Oct;107:105-121. doi: 10.1016/j.avsg.2023.12.102. Epub 2024 Apr 9. Ann Vasc Surg. 2024. PMID: 38599491 Review.
-
Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication.J Vasc Surg. 2015 Mar;61(3 Suppl):2S-41S. doi: 10.1016/j.jvs.2014.12.009. Epub 2015 Jan 28. J Vasc Surg. 2015. PMID: 25638515 Review.
Cited by
-
Quality of life and utility of patients with peripheral artery disease (PAD): a systematic review and meta-analysis.Sci Rep. 2024 Nov 21;14(1):28823. doi: 10.1038/s41598-024-80387-1. Sci Rep. 2024. PMID: 39572676 Free PMC article.
-
Hypercholesterolemia impairs collateral artery enlargement by ten-eleven translocation 1-dependent hematopoietic stem cell autonomous mechanism in a murine model of limb ischemia.JVS Vasc Sci. 2024 Apr 6;5:100203. doi: 10.1016/j.jvssci.2024.100203. eCollection 2024. JVS Vasc Sci. 2024. PMID: 38774713 Free PMC article.
-
Socioeconomic factors predict successful supervised exercise therapy completion.J Vasc Surg. 2024 Apr;79(4):904-910. doi: 10.1016/j.jvs.2023.12.008. Epub 2023 Dec 12. J Vasc Surg. 2024. PMID: 38092308 Free PMC article.
-
Current Medical Therapy and Revascularization in Peripheral Artery Disease of the Lower Limbs: Impacts on Subclinical Chronic Inflammation.Int J Mol Sci. 2023 Nov 8;24(22):16099. doi: 10.3390/ijms242216099. Int J Mol Sci. 2023. PMID: 38003290 Free PMC article. Review.
-
Perspectives on Lower Extremity Peripheral Artery Disease: A Qualitative Study of Early Diagnosis and Treatment and the Impact of Health Disparities.Popul Health Manag. 2023 Dec;26(6):387-396. doi: 10.1089/pop.2023.0095. Epub 2023 Nov 10. Popul Health Manag. 2023. PMID: 37948553 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
